Skip to content

   Pharma Publications

Neuropsychopharmacology
  • From symptom-based heterogeneity to mechanism-based profiling in youth ADHD: the promise of computational psychiatry
    Published on 2025-09-30
    12 months ago
  • Digital frontlines: leveraging AI to augment human expertise in crisis and combat situations
    Published on 2025-09-29
    12 months ago
  • Dorsomedial striatal neuroinflammation causes excessive goal-directed action control by disrupting astrocyte function
    Published on 2025-09-27
    12 months ago
  • In Memoriam: Terry A. Ketter, MD
    Published on 2025-09-26
    12 months ago
  • A review of the impact of structural racism on lived experiences of adolescents of African descent: Implications for development, brain structure, and health
    Published on 2025-09-26
    12 months ago
  • Building brain resilience through brain capital
    Published on 2025-09-26
    12 months ago
  • Role of molecularly defined lateral septum cell types and circuits in social behaviors
    Published on 2025-09-26
    12 months ago
« Previous 1 … 44 45 46 47 48 … 143 Next »
Journal of Psychopharmacology
  • Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial
    Published on 2024-10-12
    2 years ago
  • Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study
    Published on 2024-10-12
    2 years ago
  • Evaluation of the sedative-motor effects of novel GABAkine imidazodiazepines using quantitative observation techniques in rhesus monkeys
    Published on 2024-10-10
    2 years ago
  • Associative memory in alcohol-related contexts: An fMRI study with young binge drinkers
    Published on 2024-10-07
    2 years ago
  • Amygdala activity after subchronic escitalopram administration in healthy volunteers: A pharmaco-functional magnetic resonance imaging study
    Published on 2024-10-04
    2 years ago
  • Mechanisms of psilocybin on the treatment of posttraumatic stress disorder
    Published on 2024-10-03
    2 years ago
  • Unidentified CYP2D6 genotype does not affect pharmacological treatment for patients with first episode psychosis
    Published on 2024-09-30
    2 years ago
« Previous 1 … 44 45 46 47 48 … 154 Next »
European Neuropsychopharmacology
  • Ensuring safety in cannabinoid prescriptions: A call for critical assessment
    Published on 2024-07-21
    2 years ago
  • Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition
    Published on 2024-07-18
    2 years ago
  • Childhood maltreatment: A call for a standardised definition and applied framework
    Published on 2024-07-18
    2 years ago
  • Mixed features in mood episodes: Mismatch between intensity and valence in emotional responses
    Published on 2024-07-17
    2 years ago
  • Ketamine and new targets for treatment-resistant depression: A role for transforming growth factor-β1?
    Published on 2024-07-17
    2 years ago
  • Deciphering the impact of metabolic anomalies in relation to severe mental illness
    Published on 2024-07-17
    2 years ago
  • Minor physical anomalies in schizophrenia and first-degree relatives in comparison to healthy controls: A systematic review and meta-analysis
    Published on 2024-06-29
    2 years ago
« Previous 1 … 44 45 46 47 48 … 170 Next »

   Pharma Pub